Werewolf Therapeutics, Inc.
HOWL
$0.39
$0.001.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 52.68% | 22.30% | 13.75% | -17.26% | -36.13% |
| Total Depreciation and Amortization | 111.34% | -9.57% | -9.92% | -8.52% | -5.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.21% | -41.85% | -28.90% | -0.46% | 3.37% |
| Change in Net Operating Assets | -1,427.90% | -374.84% | -424.82% | -147.94% | -48.54% |
| Cash from Operations | 50.44% | 13.20% | -7.30% | -36.54% | -47.40% |
| Capital Expenditure | -- | -- | -- | 62.61% | 76.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 430.16% | -- | -- | 62.61% | 76.97% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 92.20% | 72.23% | -74.63% | -79.50% | -90.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 100.00% |
| Cash from Financing | -1,014.03% | 183.97% | -53.91% | -68.33% | -85.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.62% | 31.64% | -25.14% | -110.81% | -161.82% |